Analysts think CORT stock price could increase by 100%
May 07, 2025, 11:25 AM
-2.38%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
6 analysts think CORT stock price will increase by 99.96%. The current median analyst target is $141.27 compared to a current stock price of $70.65. The lowest analysts target is $132.31 and the highest analyst target is $157.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
